[1] Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics[J]. CA Cancer J Clin,2012,62:220-241. [2] Ozols RF, Bookman MA, Connolly DC, et al. Focus on epithelial ovarian cancer[J]. Cancer Cell,2004,5:19-24. [3] Shimbo A, Kajiyama H, Tamauchi S, et al. Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma[J]. Oncol Rep,2019,42:2323-2332. [4] Chemg JC, Chamg HM, Leumg PCK. Connective tissue growth factor mediates TGF-β1-induced low-grade serous ovarian tumor cell apoptosis[J]. Oncotarget, 2017,8:85224-85233. [5] Moran-Jones K, Gloss BS, Murali R, et al. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer[J]. Oncotarget,2015, 6:44551-44562. [6] Wamg L, He J, Xu H, et al. MiR-143 targets CTGF and exerts tumor-suppressimg functions in epithelial ovarian cancer[J]. Am J Transl Res,2016,8:2716-2726. [7] Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review[J]. Semin Oncol Nurs,2019,35:151-156. [8] Chu CY, Chang CC, Prakash E,et al.Connective tissue growth factor(CTGF) and cancer progression[J]. J Biomed Sci,2008,15:675-685. [9] Jacobson A,Cunningham JL. Connective tissue growth factor in tumor pathogenesis[J]. Fibrogenesis Tissue Repair,2012.doi:10.1186/1755-1536-5-S1-S8. [10] Tan G, Cao X, Dai Q, et al. A novel role for microRNA-129-5p in inhibitimg ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ[J]. Oncotarget,2015,6:8676-8686. [11] Wamg L, He J, Xu H, et al. miR-143 targets CTGF and exerts tumor-suppressimg functions in epithelial ovarian cancer[J]. Am J Transl Res, 2016,8:2716-2726. |